HIGHLIGHTS
- who: . and colleagues from the Dalian Medical University, China have published the research: Pharmacokinetics and safety of the two oral cefaclor formulations in healthy chinese subjects in the fasting and postprandial states, in the Journal: (JOURNAL)
- what: This trial was designed to compare the bioequivalence and safety of Cefaclor granule and Cefaclor suspension under fasting and postprandial states.
- how: The authors conducted a phase I clinical trial to compare the pharmacokinetics and safety of Cefaclor granule and Cefaclor suspension in healthy Chinese subjects in the fasting and postprandial states. Plasma concentration data were . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.